Black Diamond Therapeutic... (BDTX)
undefined
undefined%
At close: undefined
2.49
-1.78%
After-hours Dec 13, 2024, 04:05 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue - - - - - - -
Cost of Revenue 437.00K 3.24M 2.22M 600.00K 47.00K 44.00K 24.00K
Gross Profit -437.00K -3.24M -2.22M -600.00K -47.00K -44.00K -24.00K
Operating Income -86.46M -92.83M -126.87M -69.57M -8.90M -8.90M -4.12M
Interest Income 1.92M 2.03M 3.46M 4.04M 461.00K 4.00K -
Pretax Income -82.44M -88.92M -125.60M -67.25M -35.26M -8.93M -4.60M
Net Income -82.44M -84.52M -123.20M -65.48M -41.14M -8.93M -4.60M
Selling & General & Admin 27.11M 28.39M 30.04M 21.36M 7.58M 1.95M 666.00K
Research & Development 59.35M 64.44M 96.83M 48.21M 21.75M 6.95M 3.45M
Other Expenses - -354.00K -2.19M -1.72M 6.00K -16.00K -6.00K
Operating Expenses 86.46M 92.83M 126.87M 69.57M 29.33M 8.90M 4.12M
Interest Expense - - - 1K - - 65.00K
Selling & Marketing Expenses - - - - - - -
Cost & Expenses 86.46M 92.83M 126.87M 69.57M 29.33M 8.90M 4.12M
Income Tax - -4.40M -2.39M -1.77M 5.88M -27.00K 59.00K
Shares Outstanding (Basic) 43.95M 36.33M 36.19M 32.91M 35.91M 13.95M 7.20M
Shares Outstanding (Diluted) 43.95M 36.33M 36.19M 32.91M 35.91M 13.95M 7.20M
EPS (Basic) -1.88 -2.33 -3.4 -1.99 -1.15 -0.64 -0.64
EPS (Diluted) -1.88 -2.33 -3.4 -1.99 -1.15 -0.64 -0.64
EBITDA -86.02M -92.32M -126.67M -66.65M -29.29M -8.89M -4.09M
Depreciation & Amortization 437.00K 3.24M 2.22M 600.00K 47.00K 44.00K 24.00K